A world without
infectious disease.

ABOUT

WHAT IF A COMPANY USED THE SAME SCIENTIFIC BREAKTHROUGHS REVOLUTIONIZING ONCOLOGY TO FIGHT INFECTIOUS DISEASE?

Vir was created to be that company.

Vir brings together cutting-edge innovations with leading scientific expertise and management to take on some of the world’s most challenging infectious diseases for which solutions are non-existent or inadequate. Vir seeks to take a new approach, using breakthroughs in immune programming to manipulate pathogen-host interactions. The company will take a multi-program, multi-platform approach to applying these breakthroughs, guided by rigorous science and driven by medical need.

Lead investors include ARCH Venture Partners and the Bill & Melinda Gates Foundation.

Vir Biotechnology is investing in cures, treatments, and preventions for challenging viral and bacterial diseases, including those caused by drug-resistant bacteria and emerging pathogens.

CONTACT

Vir Biotechnology, Inc.

San Francisco, CA

email: info@vir.bio